Haibang Capital

Zhejiang Haibang Investment Management Co., Ltd., commonly known as Haibang Capital, is a private equity and venture capital firm established in 2010 in Hangzhou, China. The firm specializes in investing in startups and companies at various stages of development, including early and growth stages, with a focus on emerging industries such as biomedicine, new materials, new energy, environmental protection, digital information, and advanced manufacturing. Haibang Capital emphasizes support for returnee entrepreneurs—those who have studied or worked abroad and are starting businesses in China. In 2011, the firm launched its first fund aimed at assisting these returnees, thereby contributing to local economic growth and innovation. Beyond financial investment, Haibang Capital offers personalized value-added services to its portfolio companies, fostering both economic and social benefits in the Zhejiang Province and beyond.

Shan Jialiang

MD

Gang Liang

Founding Partner

Li Xie

President

Naxin Yao

Chairman and Executive Partner

39 past transactions

Jianxin Jiaren

Series A in 2024
Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.

Jinmate

Series B in 2024
Jinmate focuses on manufacturing and provides customers with stable and efficient digital intelligent manufacturing overall solutions.

MetaLenX

Series A in 2023
MetaLenX specializes in the design and manufacture of planar optical devices known as metalenses, which utilize micro-nano structures to modulate light. Employing advanced semiconductor technology, the company produces these devices in large quantities, enabling their application across various sectors, including consumer electronics, security monitoring, automotive electronics, and 5G infrastructure. MetaLenX also focuses on developing superlenses that operate across a wide spectrum, from visible to infrared wavelengths, which can be customized for specific needs. By prioritizing innovation, MetaLenX aims to lead advancements in the optical industry, making significant contributions to emerging technologies such as augmented and virtual reality, drones, and intelligent driving systems.

LYNK Pharmaceuticals

Series C in 2023
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Zhiwei Technology

Venture Round in 2023
Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.

Zhongzhiwei Technology

Series A in 2023
Zhongzhiwei Technology is a provider of network security solutions that leverages artificial intelligence and machine learning. The company aims to advance the network security industry in China, focusing on sectors such as finance, public security, government, manufacturing, and enterprise-level information security. Zhongzhiwei Technology offers a range of services, including high-quality network security solutions, large-scale attack and defense training collaboration platforms, and knowledge graph-based security solutions. By integrating advanced technologies, the company seeks to enhance cybersecurity measures and provide comprehensive support to its clients.

Jinmate

Series A in 2023
Jinmate focuses on manufacturing and provides customers with stable and efficient digital intelligent manufacturing overall solutions.

Microquanta

Series D in 2022
Microquanta, based in Hangzhou, specializes in the development and manufacturing of perovskite solar cell modules, which represent an innovative approach to solar technology. These modules are designed to deliver higher electricity conversion rates at lower costs compared to traditional solar technologies. The company's latest perovskite mini-module achieves an electricity conversion rate of 17%, surpassing its previous record of 16%. With a total funding of $10 million secured, Microquanta aims to further commercialize its technology and establish production lines within the year. By offering high energy conversion efficiency, the company provides flexible clean energy solutions to its business clients.

Healsun Biopharm

Series B in 2022
Healsun Biopharm is a biopharmaceutical company based in Hangzhou, China, specializing in research and development services for new drug development. Founded in 2015, the company offers a range of services including molecular construction, stable cell line screening, cell culture process development, protein purification, and bioanalytical method development. Healsun Biopharm focuses on preclinical drug development, providing essential technical services to global biopharmaceutical and biotechnology firms. Its platform supports antibody drug analysis, transient protein expression, and the development of antibody-conjugated drugs, enabling clients to accelerate their research processes and minimize costs.

Hengyu Biotechnology

Series A in 2022
Hengyu Biotechnology is a specialized provider of biological testing services aimed at drug developers. Founded by a scientific research team, the company focuses on delivering comprehensive biosafety testing solutions for innovative pharmaceutical companies worldwide. Its services include viral clearance process validation, cell bank validation, replicative virus testing, batch release testing, CGT bioanalysis, and process residue testing. These offerings are designed to meet regulatory filing requirements across the United States, China, and Europe, supporting the entire life cycle of biologics from research and development to marketing.

JH Cispoly

Series A in 2022
JH Cispoly specializes in the development of diagnostic technology and equipment specifically designed for gynecological tumors. The company focuses on creating innovative solutions for the early diagnosis of various types of gynecological cancers, including ovarian, cervical, and endometrial cancer. By enhancing early detection capabilities, JH Cispoly aims to improve patient outcomes and facilitate timely treatment for individuals at risk of these conditions.

DECANS

Series B in 2022
DECANS manufactures medical devices that include spine, artificial joints, and trauma systems, data acquisition, processing, and analysis systems, 3D bionic additive manufacturing for medical devices. They provide medical device design and demonstration training centers.

Jiu Zong

Series B in 2021
Jiu Zong offers main products such as include three-dimensional shape measuring instruments, LED chip packaging appearance inspection equipment, mobile phone glass cover appearance inspection equipment, mobile phone middle frame glue line inspection equipment, mobile phone middle frame flatness, straightness inspection equipment, injection molded parts Professional 3D measurement and appearance inspection equipment such as appearance inspection equipment, and sheet metal online inspection equipment.

Odianyun

Series C in 2021
Odianyun, officially known as Haiou Electric Cloud Information Technology Co., Ltd., is a leading provider of cross-platform e-commerce solutions. Established in 2015, the company specializes in the research and development of large-scale e-commerce systems that encompass back-end supply chain management and the creation of e-commerce websites. Its services cater to various channels, including PC, mobile, and physical stores, utilizing a SaaS cloud service model. Odianyun aims to support vendors in efficiently managing their retail operations and supply chains through advanced tools designed for omni-channel e-commerce. The company is committed to transforming traditional business practices by leveraging modern internet e-commerce concepts, thereby facilitating the transition to the "Internet +" era. With a focus on creating social value, Odianyun emphasizes the importance of product quality and customer service while maintaining a dedicated and efficient team.

T-Maximum

Angel Round in 2021
T-Maximum focuses on the development of CAR-T cell therapies specifically for the treatment of brain tumors. The company utilizes a unique universal CAR-T development platform that incorporates CRISPR/Cas9 gene-editing technology. This innovative approach addresses critical challenges in the field, such as graft-versus-host disease and rejection of allogeneic immune cells. T-Maximum's allogeneic CAR-T cells are designed to have prolonged survival in patients, demonstrating promising therapeutic effects that enhance accessibility to CAR-T therapies for those suffering from brain tumors. The company's commitment to advancing CAR-T cell therapy is supported by its independently developed intellectual property, positioning it as a key player in the treatment of this complex medical condition.

TYK Medicines

Series B in 2021
TYK Medicines, Inc. is a biotechnology company based in Shanghai, China, established in 2017. The company specializes in the research and development of anti-cancer drugs and operates various laboratories, including biological, cell culture, and chemical analysis facilities. TYK Medicines focuses on drug discovery and is dedicated to the development and commercialization of pharmaceutical products aimed at addressing cancer.

Healsun Biopharm

Series A in 2021
Healsun Biopharm is a biopharmaceutical company based in Hangzhou, China, specializing in research and development services for new drug development. Founded in 2015, the company offers a range of services including molecular construction, stable cell line screening, cell culture process development, protein purification, and bioanalytical method development. Healsun Biopharm focuses on preclinical drug development, providing essential technical services to global biopharmaceutical and biotechnology firms. Its platform supports antibody drug analysis, transient protein expression, and the development of antibody-conjugated drugs, enabling clients to accelerate their research processes and minimize costs.

YIBEI

Series A in 2021
YIBEI is a medical technology company based on digital services. They are passionate about the use of artificial intelligence, big data, and cloud computing technologies to strengthen the medical and health industries. YIBEI provides hospital management platforms, e-commerce platforms, financial platforms, and supplier material management platforms, integrating the scientific into the interconnected industrial environment of the entire industrial chain.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company specializing in the development and sale of protein and peptide drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company focuses on therapeutic areas such as diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neuro-degenerative conditions. Sciwind's innovative drug candidates are particularly targeted at metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for healthcare professionals and their patients.

Dangwu

Series A in 2021
Dangwu is a big data platform that has helped many customers in industries such as electric power, the chemical industry, transportation, government affairs, and retail realize domestic substitution.

Joinhealth Technology

Series A in 2019
Hangzhou Joinhealth Technology Co., Ltd. specializes in developing software solutions for medical follow-up and post-hospital management. Founded in 2015 and headquartered in Hangzhou, China, the company offers a range of products including systems for hospital follow-up, VIP customer management, chronic disease management, and maternal and child health. Joinhealth Technology integrates artificial intelligence and advanced technologies like the Internet and Internet of Things to enhance patient management. By shifting the focus from disease treatment to comprehensive disease management, the company facilitates intelligent management of patients throughout their healthcare journey, from hospital care to home and potential re-admission.

Jianhai Technology

Series A in 2019
Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

TranslateGo

Angel Round in 2017
TranslateGo is a company that specializes in document translation services, utilizing artificial intelligence and big data to deliver accurate translations in nearly 100 languages. Their offerings include automated translation solutions, human translation, and features such as plagiarism checking and a neural network-based intelligent translation system. The platform aims to provide users with a smooth reading experience while ensuring the quality and reliability of translations across various documents.

YIBEI

Angel Round in 2017
YIBEI is a medical technology company based on digital services. They are passionate about the use of artificial intelligence, big data, and cloud computing technologies to strengthen the medical and health industries. YIBEI provides hospital management platforms, e-commerce platforms, financial platforms, and supplier material management platforms, integrating the scientific into the interconnected industrial environment of the entire industrial chain.

Realy Technology

Series A in 2017
REALY is a manufacturer of medical equipment and devices that focuses on developing at-home diagnostic tools. Their point-of-care testing (POCT) products facilitate medical testing by delivering rapid diagnostic information. This enables patients to receive immediate insights into their health conditions, empowering them to make informed medical decisions promptly.

Power Data

Series A in 2016
Baohe Data is a technological big data and artificial intelligence service provider. They provide digital services such as discipline construction, scientific research, talent training, quality management, achievement transformation, and the integration of production and education. It offers services for education authorities, universities, and technology enterprise R and D institutions.

e-LinkCare

Series A in 2016
e-LinkCare is a tech company that manufactures medical equipment, including the AccuGenceTM multi-monitoring system and the UBREATHTM spirometer system, as well as integrated digital and mobile healthcare solutions. They provide solutions for respiratory diseases, cardiovascular diseases, and metabolic diseases. They provide comprehensive chronic disease solutions for professional and home care.

DECANS

Angel Round in 2016
DECANS manufactures medical devices that include spine, artificial joints, and trauma systems, data acquisition, processing, and analysis systems, 3D bionic additive manufacturing for medical devices. They provide medical device design and demonstration training centers.

IMPACT Therapeutics

Series B in 2016
IMPACT Therapeutics, Inc. is a biotechnology company based in Shanghai, China, focused on discovering, developing, and commercializing innovative therapeutics for cancer and other life-threatening diseases. Founded in 2009, the company is dedicated to creating targeted anti-cancer treatments that leverage the concept of synthetic lethality. Its research and development efforts include a variety of novel drug projects, such as PARP inhibitors, Wee1 inhibitors, and agents targeting the Hedgehog pathway, among other DNA damage response (DDR) agents. Through its commitment to advancing targeted therapies, IMPACT Therapeutics aims to provide patients with new, effective treatment options for challenging medical conditions.

Realy Technology

Angel Round in 2015
REALY is a manufacturer of medical equipment and devices that focuses on developing at-home diagnostic tools. Their point-of-care testing (POCT) products facilitate medical testing by delivering rapid diagnostic information. This enables patients to receive immediate insights into their health conditions, empowering them to make informed medical decisions promptly.

Scooper Technology

Series A in 2015
SCOOPER specializes in providing comprehensive solutions and services tailored for the public security industry. The company focuses on research and development, production, and sales of software and hardware for public security emergency platforms. Its service offerings encompass urban emergency response, urban lifeline monitoring, earthquake disaster mitigation, public health initiatives, grassroots governance, as well as smart civil air defense, smart mines, and smart parks. Through these diverse areas, SCOOPER aims to enhance public safety and improve emergency management systems.

Zylox Medical Device

Series A in 2015
Zylox Medical Device Co. was established in 2012 in Hangzhou by a team of experienced professionals who returned to China after working in prominent medical device companies in the US and Europe. The company specializes in developing innovative interventional and implantable devices for peripheral and neurovascular applications. Its product portfolio includes a range of devices such as PTA balloons, drug-coated PTA balloons, stents, and thrombectomy devices. Zylox is committed to providing high-quality medical solutions aimed at improving patient care and enhancing the capabilities of healthcare professionals. The company continues to expand its product offerings to address various vascular conditions both in China and internationally.

Techbridge

Series C in 2015
Techbridge is a research and development company for the triple-play video communication platform and its applications in different fields. It has been deeply integrated with a number of industrial applications and launched a series of industries that provide audio and video services.

InnoTek

Series A in 2015
Zhejiang InnoTek Co., Ltd. is engaged in the development of wireless sensor technology products tailored for Internet-of-Things applications and personal positioning services. The company specializes in smart parking management and guidance systems, judicial community correction systems, and integrated personal positioning monitoring systems. Its offerings are utilized across various sectors, including smart traffic management and smart judicature. InnoTek's software solutions encompass parking information collection, unified charging management, and intelligent toll terminal charging management, which facilitate efficient parking management for car park owners and policymakers. Established in 2011 and headquartered in Hangzhou, China, InnoTek collaborates strategically with prominent telecommunications companies to enhance its technology and service offerings.

Gunma Wangluo

Angel Round in 2015
Gunma Wangluo provides management software, wechat ecological mini program, and hardware equipment services. They also provide billing and flexible management of stores.

Zannan

Series C in 2015
Zannan Technology is a fast-growing high-tech company focused on scientific and technological innovation, and it is dedicated to the research and development, production, and sale of high-performance catalysts and new polymer materials.

Das Security

Angel Round in 2011
Das Security is a provider of information security technology services, offering many comprehensive solutions like application security, database security, website security monitoring, and a digital security management platform. The company maintains its corporate purpose of creating a safe and credible digital world, supports, customer success, responsibility first, open innovation, and people-oriented, common growth as the company's values, and positions itself as the security cornerstone of digitalization. It is committed to leading the global digital security industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.